Pharmacokinetic Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02452931
Recruitment Status : Completed
First Posted : May 25, 2015
Last Update Posted : September 10, 2018
Information provided by (Responsible Party):
Tolmar Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 5, 2018
  Actual Study Completion Date : September 5, 2018